A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05299424 · RECRUITING
Trial details
- NCT number
- NCT05299424
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2026-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.